TABLE 3.
IgM ELISA principle | Components
|
Sera from patients with:
|
||||||
---|---|---|---|---|---|---|---|---|
Solid phase | Conjugate | Primary infections (n = 12)
|
Previous infections (n = 20)
|
RA (n = 23)
|
||||
No. pos.a | Sensitivity (%) | No. pos. | Specificity (%) | No. pos. | Specificity (%) | |||
Indirect | p13-p18 | Anti-human IgM-POD | 12 | 100.0 | 0 | 100.0 | 12 | 47.8 |
μc | Anti-human IgM | p23-p18-POD | 12 | 100.0 | 0 | 100.0 | 0 | 100.0 |
pos., positive.